non-linear least square fitting curve Search Results


90
GraphPad Software Inc variable slope dose-response curve (prism)
Variable Slope Dose Response Curve (Prism), supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/variable slope dose-response curve (prism)/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
variable slope dose-response curve (prism) - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
Jandel Engineering nonlinear curve fit program sigmaplot
Nonlinear Curve Fit Program Sigmaplot, supplied by Jandel Engineering, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear curve fit program sigmaplot/product/Jandel Engineering
Average 90 stars, based on 1 article reviews
nonlinear curve fit program sigmaplot - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SYSTAT nonlinear, least-squares curve fitting
Nonlinear, Least Squares Curve Fitting, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/nonlinear, least-squares curve fitting/product/SYSTAT
Average 90 stars, based on 1 article reviews
nonlinear, least-squares curve fitting - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear log inhibitor vs. normalized response curve fit function
Non Linear Log Inhibitor Vs. Normalized Response Curve Fit Function, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear log inhibitor vs. normalized response curve fit function/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear log inhibitor vs. normalized response curve fit function - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear least squares fit to a single site binding model graphpad v7.0
Non Linear Least Squares Fit To A Single Site Binding Model Graphpad V7.0, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear least squares fit to a single site binding model graphpad v7.0/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear least squares fit to a single site binding model graphpad v7.0 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
OriginLab corp non-linear least squares fit to a one-site binding model
Non Linear Least Squares Fit To A One Site Binding Model, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear least squares fit to a one-site binding model/product/OriginLab corp
Average 90 stars, based on 1 article reviews
non-linear least squares fit to a one-site binding model - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
SYSTAT weighted non-linear least-squares fitting procedure
Weighted Non Linear Least Squares Fitting Procedure, supplied by SYSTAT, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/weighted non-linear least-squares fitting procedure/product/SYSTAT
Average 90 stars, based on 1 article reviews
weighted non-linear least-squares fitting procedure - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc fitted curve 4-parameter non-linear regression
Fitted Curve 4 Parameter Non Linear Regression, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/fitted curve 4-parameter non-linear regression/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
fitted curve 4-parameter non-linear regression - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
OriginLab corp non-linear curve fitting/growth/sigmoidal/dose–response fitting functions originpro 8.6.0 b70
Non Linear Curve Fitting/Growth/Sigmoidal/Dose–Response Fitting Functions Originpro 8.6.0 B70, supplied by OriginLab corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear curve fitting/growth/sigmoidal/dose–response fitting functions originpro 8.6.0 b70/product/OriginLab corp
Average 90 stars, based on 1 article reviews
non-linear curve fitting/growth/sigmoidal/dose–response fitting functions originpro 8.6.0 b70 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc non-linear curve fit of percent cytotoxicity
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Non Linear Curve Fit Of Percent Cytotoxicity, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/non-linear curve fit of percent cytotoxicity/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
non-linear curve fit of percent cytotoxicity - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc saturation binding curve
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Saturation Binding Curve, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/saturation binding curve/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
saturation binding curve - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc single binding site curve fitting algorithm
ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative <t>cytotoxicity</t> observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.
Single Binding Site Curve Fitting Algorithm, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/single binding site curve fitting algorithm/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
single binding site curve fitting algorithm - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative cytotoxicity observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.

Journal: Oncotarget

Article Title: Molecular imaging reveals biodistribution of P-cadherin LP-DART bispecific and trafficking of adoptively transferred T cells in mouse xenograft model

doi: 10.18632/oncotarget.27544

Figure Lengend Snippet: ELISA based assay was used to evaluate the effect of VT680 labeling on binding of P-cadherin LP-DART to human P-cadherin and human CD3. The proteins were coated on to the plates and incubated with serial dilutions of P-cadherin LP-DART-VT680 or Control LP-DART-VT680 for 1 hr at 37°C. The bound P-cadherin LP-DART was quantified using IgG-HRP conjugate followed by calorimetric quantitation. ( A ) The labeling of VT680 to P-cadherin LP-DART had a DOL dependent effect on binding to human P-cadherin and Control LP-DART had no binding to human P-cadherin. ( B ) The labeling of VT680 to P-cadherin LP-DART and Control LP-DART affected binding to human CD3. P-cadherin LP-DART retained moderate binding even at a DOL of 2.0, whereas Control LP-DART lost its binding to human CD3 protein. ( C ) CTL Assay: Firefly luciferase expressing HCT116 cells and expanded human CD3+ T lymphocytes were co-incubated with increasing concentrations of P-cadherin LP-DART with different DOL of VT680. After 24 hr the remaining viable cells were quantified by measuring the luciferase activity. The relative cytotoxicity observed at various concentrations of P-cadherin LP-DART-VT680 was plotted against the PBS treated samples. VT680 conjugation decreased the cytotoxic ability in a DOL dependent manner.

Article Snippet: EC50 was determined by non-linear curve fit of percent cytotoxicity using GraphPad Prism 7.04 software (GraphPad Software).

Techniques: Enzyme-linked Immunosorbent Assay, Labeling, Binding Assay, Incubation, Control, Quantitation Assay, CTL Assay, Luciferase, Expressing, Activity Assay, Conjugation Assay